The movement of ions across specific channels embedded on the membrane of individual cardiomyocytes is crucial for the generation and propagation of the cardiac electrical impulse. Emerging evidence over the last 20 years strongly suggests that the normal electrical function of the heart is the result of dynamic interactions of membrane ion channels working in an orchestrated fashion as part of complex molecular networks. Such networks work together with exquisite temporal precision to generate each action potential and contraction. Macromolecular complexes play crucial roles in transcription, translation, oligomerization, trafficking, membrane retention, glycosylation, posttranslational modification, turnover, function and degradation of all cardiac ion channels known to date. In addition, the accurate timing of each cardiac beat and contraction demands, a comparable precision on the assembly and organizations of sodium, calcium and potassium channel complexes within specific subcellular microdomains, where physical proximity allows for prompt and efficient interaction. This review article, part of the Compendium on Sudden Cardiac Death, discusses the major issues related to the role of ion channel macromolecular assemblies in normal cardiac electrical function and the mechanisms of arrhythmias leading to sudden cardiac death. It provides an idea of how these issues are being addressed in the laboratory and in the clinic, which important questions remain unanswered, and what future research will be needed to improve knowledge and advance therapy.
Introduction
Fundamental research conducted over the last 20 years has led to an explosion of knowledge on the genetic and molecular mechanisms that regulate the function of cardiac ion channels. One of the most important outcomes of such new understanding has been the realization that the traditional reductionist view that ionic currents are the expression of distinct proteins that are fixed and function independently expressed on an intracellular or surface membrane is no longer tenable. An ion channel protein may encounter and interact with hundreds of other proteins during its lifespan, from biosynthesis until degradation. Such a complex regulation over time and space suggests an important plasticity for these protein complexes which is a major determinant of cardiomyocyte function, including excitability, excitation-contraction (e-c) coupling, intercellular communication and the pathogenesis of arrhythmias. This article is part of the Circulation Research Compendium on Sudden Cardiac Death. It reviews research on many of the currently known multicomponent assemblies formed by the main cardiac ion channels with their protein partners. It looks also at the possible role that such assemblies may have in the molecular underpinnings of the normal electrical function of the cardiomyocyte and the mechanisms of complex cardiac arrhythmias and sudden cardiac death (SCD). We are focusing on cis-interacting proteins, i.e. within the same cell. While there is emerging evidence for important roles of proteins such as the β-subunits of the voltage-gated sodium channels in trans-interactions as cell-adhesion molecules, 1 this aspect is not addressed in this review.
a. Ion channel macromolecular complexes
Macromolecular complexes consist of a handful to several thousand individual components, including proteins, nucleic acids, carbohydrates and lipids, and perform a wide array of vital tasks in the cell. 2 As such, they are essential to the proper functioning of all cellular processes, including metabolism, cell signaling, gene expression, trafficking, cell cycle regulation and the formation of subcellular structures. 3, 4 In the cardiac myocyte, macromolecular complexes also play crucial roles in converting energy, generating and propagating electrical signals and mediating contractility, as well intercellular communication. 5, 6 To achieve these functions, complex molecular networks work together with exquisite temporal precision to generate each AP and contraction. The accurate timing of the molecular events demands, in addition, a comparable precision on the location of each molecule within the cell. Indeed, molecular networks assemble and organize within specific subcellular microdomains, where physical proximity allows for prompt and efficient interaction. 7 For example, Petitprez et al 8 described two separate pools of sodium channels in ventricular cardiomyocytes. One subpopulation localizes at the lateral membrane of the myocytes, while the other localizes at the intercalated disc (ID), and a recent study has shown that Na V 1.5 and Kir2.1 co-localize at both the ID and the lateral membrane, which is important for mutual regulation and the control of cardiac excitability. 9 
b. Genetic cardiac channelopathies
Genetic cardiac channelopathies were identified over 20 years ago. 10 As of today, more than 35 distinct genes encoding ion channel subunits or regulatory proteins are known to be linked to arrhythmogenic syndromes. 11 The estimated prevalence of cardiac channelopathies Na V 1.5 channels at the lateral membranes of myocytes (Fig. 3) . 25, 26 While the role of the SIV-motif and SAP97 at the ID remains to be clarified, neither truncated channels (ΔSIV), nor the cardiac ablation of SAP97 were sufficient to perturb the expression of Na V 1.5 at the ID of mouse cardiac cells ( Fig. 2A and 2B) . 25, 26 Two other distinct protein-protein interacting domains are well-recognized in the C-terminal sequence of Na V 1.5 ( Fig. 1) : 27 the IQ-motif allowing specific interaction with calmodulin and the PY-motif, a domain found in membrane proteins permitting the binding of ubiquitin-ligases of the Nedd4/ Nedd4-like family (reviewed in 28 ). While the structural details and roles of the interaction of calmodulin and Na V 1.5 have been controversial, a recent study 29 suggested a model where calmodulin may be an essential molecular player in the transitions between the different channel states. 29 b. Mutations in genes coding for Na V 
channel interacting proteins and associated disorders
Among the long list of proteins interacting with Nav1.5 ( Fig. 1 ), 30 mutations in the genes coding for 6 of them were reported in patients with altered electrical function that may lead to SCD. Also important, more than 20 naturally-occurring mutations have been described in the genes coding for the 4 β-voltage-gated sodium channel subunits. 31 These mutations were found in patients with SCD phenotypes such as BrS, sudden infant death syndrome (SIDS), sudden unexpected nocturnal death syndrome (SUNDS), and idiopathic VF. The molecular mechanisms underlying the observed phenotypes were diverse, but the majority of these β-subunit mutations reduced the Na V 1.5-mediated I Na . 31 We review here briefly the evidence demonstrating that mutations of the proteins of the Na V 1.5 macromolecular complexes cause severe electrical disturbances.
α1-syntrophin-Na V 1.5 is part of the dystrophin multi-protein complex; Gavillet et al 32 demonstrated that Na V 1.5 interacts with dystrophin via adaptor syntrophin proteins (see also Fig. 2A) . 32 Similar to the binding with SAP97, this interaction is dependent on the last three residues (SIV) of the Na V 1.5 protein. Two missense mutations in SNTA1, encoding α1-syntrophin, have been described in patients with congenital LQTS. 33 The SNTA1 mutation, p.A390V was reported to disrupt a macromolecular complex comprising neuronal nitric oxide synthase (nNOS), plasma membrane Ca-ATPase type 4b and Na V 1.5 with syntrophin. 33 The mutant syntrophin protein increased the late Na + current, a finding that is consistent with the LQTS phenotype. Increased nitrosylation of Na V 1.5, when the mutant syntrophin was co-expressed in HEK293 cells was observed. Further, the mutation SNTA1 p.A257G was found in 3 unrelated LQTS probands. 34 While no increase in the late I Na was observed with this variant, significant increase in peak I Na and slowed fast inactivation resulted from the co-expression of this mutant syntrophin. The gene SNTA1 was also found to be mutated in 8 cases of SIDS patients and these variants caused an increase of the Na V 1.5-mediated late I Na which was inhibited by nNOS inhibitors. 34 Caveolin-3-Caveolin proteins are important components of caveolae, which are cholesterol-rich plasma membrane invaginations where signaling molecules and ion channels are enriched. Caveolin-3 is encoded by the gene CAV3; it is the predominant caveolin isoform expressed in cardiac cells. CAV3 was found to be mutated in patients with congenital LQTS and SIDS. 35, 36 Caveolin-3 was co-immunoprecipitated with Na V 1.5 in rat cardiac tissue and HEK293 cells. 35, 37 Immunofluorescence stainings showed that the two proteins are co-localized at the lateral membrane of the cardiomyocytes. 35 The coexpression of Na V 1.5 and the LQTS and SIDS mutants of caveolin-3 in HEK293 cells were also shown to increase the late Na + inward current. 35, 36 It has been proposed that both CAV3 and SNTA1 mutations share a common mechanism in releasing inhibition of nNOS, leading to an increase in Na V 1.5 S-nitrosylation and, as a result, augmented late INa. 30 Glycerol-3-phosphate dehydrogenase 1 like protein-Glycerol-3-phosphate dehydrogenase like protein (GPD1L) is an enzyme homolog to glycerol-3-phosphate dehydrogenase 1, a key enzyme of the respiratory chain. In 2002, a locus on chromosome 3 in a family with BrS was detected, and later a missense mutation in the gene coding for GPD1L was observed. 38, 39 Co-expression experiments showed that mutant GPD1L reduced the Na V 1.5-mediated INa. Three other GPD1L mutations have been described in babies that died of SIDS. 40 Expression of these SIDS variants in neonatal mouse cardiomyocytes also decreased the INa, demonstrating that SIDS patients may have decreased I Na similarly to BrS. The mechanisms by which the mutations of GPD1L reduce the I Na have been investigated in expression systems. 41 It is proposed that Ser-1503 of Na V 1.5 is phosphorylated by protein kinase C (PKC) and that this reduces the INa. It has been shown that the activity of PKC depends on GPD1L function, and that the mutant GPD1L variants lead to a further decrease in the I Na following a diacylglycerol-dependent stimulation of PKC. 41 Another possible mechanism is that the GPD1L mutant increases nicotinamide adenine dinucleotide phosphate and via PKC effects on mitochondria, and this decreases reactive oxygen species, which then reduce the I Na by yet unknown mechanisms. 42 MOG1-Multi-copy suppressor of gsp1 (MOG1) is a 29-kd protein encoded by the RANGRF gene. MOG1 interacts with the intracellular loop of Na V 1.5 between domains II and III. 43 The two proteins also co-localize at the IDs in mouse ventricular cells. MOG1 coexpression in HEK293 cells increased the Na V 1.5-mediated current without altering its biophysical properties, suggesting that MOG1 is a co-factor for optimal channel expression at the cell membrane. A human study described one BrS variant of MOG1 that reduced the expression of Na V 1.5 at the cell membrane of rat atrial cardiomyocytes and decreased the INa. 44 The details about how MOG1 regulates the expression of Na V 1.5 are still to be investigated.
Fibroblast growth factor homologous factors (FGFs)-FGFs are cytosolic proteins that can modulate both cardiac Na + and Ca 2+ channels. 49 The proximal part of the Cterminal domain of Na v 1.5 has been shown to bind to murine FGF13 -and human FGF12 (Fig. 1) . 50, 51 Knockdown of FGF13 in murine ventricular myocytes decreased I Na and channel availability. 50 Interestingly, a genetic variant of the gene coding for human FGF12 (p.Q7R) was identified in one BrS patient. 51 When expressed in rat myocytes, this variant reduced I Na and channel availability, hence leading to a loss of function which is consistent with the BrS phenotype.
Synapse Associated Protein 97-SAP97 regulates the targeting, localization and function of cardiac K + and sodium channels via their PDZ-domain binding motifs located in the C-termini. The interaction between SAP97 and Na V 1.5 has been demonstrated independently by the Abriel and the Jalife labs. 8, 9, 25 While there is strong experimental evidence for a direct interaction between these two proteins via the Na V 1.5-SIV motif and a SAP97 PDZ-domain, the exact role of SAP97 on the regulation of Na V 1.5 function remains to be clarified. 26 A mutation found in one patient with BrS modified the valine of the SIV motif of Na V 1.5 into a methionine. This mutation was shown to specifically reduce the interaction with SAP97, but not α1-syntrophin. In parallel the mutation decreased the number of Na V 1.5 channels and I Na . 25 It seems likely that genetic variants in DLG1, the gene coding for SAP97, will be found in patients with inherited channelopathies associated to SCD.
Calcium channel macromolecular complexes
The voltage-gated L-type calcium channel, Ca V 1.2, is the main pathway for the entry of calcium into cardiac cells. 52 The pore-forming Ca V α 1 subunit carries the main biophysical and pharmacological properties of the channel that plays a key role in e-c coupling and AP duration. The Ca V α 1 subunit is modulated by interactions with different accessory subunits (Fig. 4) . It is associated with 4 different β-isoforms (Ca V β1 to 4) and 4 different α 2 -δ-isoforms (Ca V α 2 -δ1 to 4). Both Ca v β and Ca v α 2 -δ have been shown to play dual roles in regulating both the biophysical properties and trafficking of Ca V channels. In addition to these regulatory subunits, the γ subunits (8 isoforms) have been described as a third class of accessory subunits. 53 In cardiomyocytes, the fully functional Ca V 1.2 channel which is composed of at least Ca V α 1 , Ca V β, and Ca V α 1 -δ subunits (Fig. 4) can be considered as the main core macromolecular calcium channel complex.
a. Ca V 1.2 interacting proteins
All four Ca V βs increase the Ca 2+ current when they are co-expressed in heterologous expression systems along with a Ca V α 1 subunit. Ca V βs also alter the voltage dependence and kinetics of activation and inactivation. Furthermore, Ca V β subunits either regulate or are needed for the modulation of Ca V α 1 by protein kinases, G proteins, ubiquitin ligases of the Nedd4 family, and small RGK proteins (Fig. 4) . 54, 55 Ca V β proteins have also been shown to interact with Ahnak1, 56 a protein involved in the protein kinase A (PKA)-mediated control of the Ca V 1.2 channel. Altogether, these data demonstrate that Ca V β subunits play a pivotal role in the localization and regulation of cardiac calcium channels.
The Ca V α 1 -δ auxiliary subunits are the product of a single gene that is post-translationally cleaved into α2 and δ peptides and remain associated via disulfide bonds. 57 Only Ca V α 1 -δ1 and Ca V α 1 -δ2 proteins have been found to be expressed in mouse heart. 58 Co-expression of the Ca V α 1 -δ subunit, along with Ca V α 1 and Ca v β subunits, accelerated activation and deactivation kinetics and significantly increased I Ca . 58 Animals lacking the Ca V α 1 -δ1 subunit demonstrated reduced basal myocardial contractility and relaxation and decreased Ltype Ca 2+ peak current amplitude. 59 Ca V α 1 -δ1 has been recently shown to be essential in the regulation of the Ca V 1.2 channel cell surface density mediated by the deubiquitylase USP2-45. 60 The Ca V γ proteins consist of 4 transmembrane domains with intracellular N-and C-terminal ends. In the human heart, only Ca V γ4, 6, 7, and 8 have been found to be expressed 53 The Ca V γ subunits differentially modulate calcium channel function when co-expressed with the Ca V β1b and Ca V α 1 -δ1 subunits, altering both activation and inactivation properties. 53 The effects of Ca v γ on Ca v 1.2 function are dependent on the subtype of Ca v β subunit. 53 In cardiac myocytes, Ca v 1.2 channels are mainly localized in the t-tubular system (Fig. 5) . 61 L-type calcium channels are _ 3 -9 -fold enriched in the t-tubule membrane than on the extra-tubular surface sarcolemma. Within the t-tubule, studies have estimated that ~75% of the L-type calcium channels are localized in the dyad domains ( Fig. 5) , thus constituting the main Ca v 1.2 macromolecular complex in cardiac cells. The dyad represents a small area where Ca v 1.2 channels, situated on the cytoplasmic side of the plasma membrane, are in opposition to the type-2 ryanodine receptors (RyR2) that are situated on the membrane of the sarcoplasmic reticulum (SR). An essential component of the dyadic cleft is junctophilin 2 (JPH2) (Fig. 5 ). JPH2 is a cleft protein that anchors the T-tubular membrane to the SR membrane; doing so it plays a key role in maintenance and function of that space. 62 In JPH2 knock-down mice, reduction in the number of dyads was observed 63 suggesting that JPH2 is responsible for maintaining the dyadic structure A calcium-binding protein, sorcin, expressed in cardiac cells, has also been shown to interact with both Ca v 1.2 and RyR2. 64 Finally, PKA and Ca 2+ /CaM-dependent protein kinase II (CaMKII), which are known to mediate the regulation of Ca v 1.2 channel activity via their interactions with the C-terminal of the Ca V α 1 C subunit, have also been shown to be part of the dyad. 65 Recently, other partner proteins have been described to be important to regulate Ca V 1.2 expression at the t-tubule. Amphiphysin 2, also called Bridging Integrator 1 (BIN1), belongs to the BAR domain proteins superfamily and is involved in membrane invagination. 66 Hong and colleagues have shown that BIN1 is expressed at the t-tubules, 66 initiates t-tubule genesis and delivers Ca V 1.2 to t-tubules. 66 Ahnak1 is indirectly associated with the L-type Ca 2+ channel via its β 2 -subunit and has been shown to be located at the sarcolemma and ttubules of cardiomyocytes. 56 Similar to BIN1, the exact localization within the t-tubule system is not known. Nevertheless, its implication in the regulation of I Ca via the β-adrenergic pathway suggests the presence of Ahnak1 and Ca V 1.2 channels in extra-dyad complexes. Dysferlin, a member of the ferlin family, has recently been shown to be expressed mainly at the ID of cardiomyocytes and is also present at the t-tubules. 67 These observations suggest that other Ca V 1.2 macromolecular complexes, which may be caveolin-3-dependent, also exist in the extra-dyadic compartment (Fig. 5) . Recently, a subpopulation of Ca V 1.2 channels that is located in the caveolae has been found to be part of a macromolecular signaling complex including β2-adrenergic receptor, adenylate cyclase, protein phosphatase 2A, and PKA. 68 Calcineurin, another interacting/regulating protein of Ca V 1.2 channels, has also been shown to be present in caveolae and the t-tubule system. 69 Via its association with the adapter protein AKAP5, calcineurin interacts with Cav-3. 70 Altogether, these findings suggest the presence of t-tubular distinct Ca V 1.2 macromolecular complexes that are also present in extra-dyadic compartments (Fig. 5 ).
In parallel, other groups have demonstrated that a subpopulation of Ca V 1.2 channels is localized to caveolae in the extra-T-tubular lateral membrane of ventricular cardiomyocytes (Fig. 5 ), thus suggesting that at least a third Ca V 1.2 macromolecular complex exists. 68 
b. Mutations in genes coding for calcium channel interacting proteins and associated disorders
Mutations in genes coding for calcium channel accessory subunits have been linked to BrS and short QT syndrome type-6. 71, 72 A loss-of-function mutation (p.S481L) of the CACNB2 gene, encoding the Ca v β2 subunit, was found in a BrS patient. 71 Despite the large I Ca mutation-induced decrease in heterologous expression systems, no reduction of Ca V 1.2 channel number has been observed at the plasma membrane. This suggests another mechanism of Cav regulation than the traffic defect that is generally observed in BrS. Templin et al. reported a mutation (p.S755T) in CACNA2D1, the gene encoding the Ca V α 2 -δ1 subunit, in a SCD patient with SQTS. 72 An important decrease of the I Ca was observed with the expression of the mutant variant without any modification of the protein expression, thus suggesting that the single channel biophysical properties of the L-type channel were altered.
The p.I5236T mutation of Ahnak1, identified in patients with hypertrophic cardiomyopathy, 73 increased the I Ca as well as shifted slightly leftward its voltage dependence, 73 similar to what has been observed after PKA activation. It is proposed that Ahnak1 may be an important target of PKA-mediated phosphorylation in the enhancement of L-type I Ca by the β-adrenergic receptor type 2 (β-AR2). Furthermore, three other Ahnak1 variants were identified in hypertrophic and dilated cardiomyopathy patients. 74 Contrary to what has been proposed in the former study, it was recently found that Ahnak1 is not essential for β-adrenergic up-regulation of I Ca in mice. Instead, Ahnak1 interacts with the Ca v β subunit in order to modulate the β-adrenergic response of I Ca . 74 
Potassium channel macromolecular complexes and associated disorders
Cardiac potassium channel proteins are coded by more than 40 different genes. 75 In addition, a number of auxiliary subunits and associated proteins are involved in the trafficking, distribution and anchoring of potassium channels at specific microdomains at the plasma membrane, and contribute to their organization in macromolecular complexes. 76 Such partners help in the control of potassium channel expression and biophysical properties, thus regulating the plasticity of cardiac electrical activity both under normal conditions and in disease states. In this section we review the interactions of the major potassium channels as part of macromolecular assemblies and the role of such assemblies in cardiac excitation and repolarization.
a. The Strong Inward Rectifying Potassium Channels
Among the three strong inward-rectifying potassium channels (Kir2.1, 2.2 and 2.3) that express in the heart, Kir2.1 is the most abundant in the ventricles. Kir channels are responsible for I K1 and are involved in the depolarization, repolarization and resting phases of the cardiac AP. 77 Kir subunits assemble to form tetrameric channels in many cell types, including cardiac myocytes. 78, 79 I K1 contributes significant repolarizing current between -30 and -80 mV, and thus is responsible for the terminal phase of the AP. 80 In addition, it serves as the primary conductance controlling the resting membrane potential in ventricular myocytes. 81 These channels show strong rectification between -50 and 0 mV, which means that they remain closed during the AP plateau; they only open when the membrane potential repolarizes to levels between -30 and -80 mV, which in the normal AP occurs during the late phases of the AP. Rectification is achieved by a voltage-dependent blockade by intracellular magnesium and/or polyamines such as putrescine, spermine and spermidine, 82 which interact with at least three amino acid residues located inside the pore of the channel. 79 Loss of function mutations of Kir2.1 have been identified in patients affected by AndersenTawil Syndrome (ATS), which is also referred to as LQTS type 7 and is characterized by delayed repolarization. 83 Since in addition to the heart Kir2.1 is also expressed in other organs such as skeletal muscle, ATS is associated with hypokalemic periodic paralysis and skeletal developmental abnormalities. 83 In the heart, reduction of I K1 leads to QT prolongation and predisposes to arrhythmias; yet QT prolongation is less prominent in patients presenting ATS than in other types of LQTS. 84 Moreover, while ATS patients do develop ventricular tachyarrhythmias, including torsades de pointes, SCD is rare in these patients. 85 Only 3 cases of Kir2.1 gain-of function mutation have been reported. In 2005, Xia et al reported on A Kir2.1 gain-of-function mutation (V93I) in a large Chinese family with atrial fibrillation. 86 Subsequently, two different gain-of-function mutations (D172N and E299V) in the KCNJ2 gene were reported in patients with short QT syndrome type 3 (SQTS3). 17, 87 Increased I K1 shortens repolarization and the QT interval, and exerts a proarrhythmic effect both in the atria and the ventricles. 88 
b. Kir2 channels have multiple functional partners
In 2001, Leonoudakis et al identified a direct association of Kir2.1, Kir2.2 and Kir2.3 with SAP97. 89 They further demonstrated that a complex composed of members of the MAGUK protein family (SAP97, CASK, Veli, and Mint1) associates with Kir2 channels via the Cterminal PDZ-binding motif. 90 Also using in vitro protein interaction assays they showed that SAP97, Veli-1, or Veli-3 binds directly to the Kir2.2 C terminus and recruits CASK and proposed a model whereby Kir2.2 associates with distinct SAP97-CASK-Veli-Mint1 complexes. Subsequently, using immunoaffinity purification and affinity chromatography from skeletal and cardiac muscle and brain, they discovered that α1-, β1-, and β2-syntrophin, dystrophin, and dystrobrevin, all members of the dystrophin-associated protein complex, also interact with Kir2 channels. 76 In this regard, cardiomyocytes from the dystrophin-deficient mdx mouse show a small but significant decrease in Kir2.1 protein. 32 It is also possible that dystrophin related proteins contribute to determining the subcellular localization of Kir2.x channels in cardiomyocytes, similar to what has been demonstrated for Na V 1.5 channels. 32 As demonstrated by affinity pull-down experiments Kir2.1-3, and Kir4.1 all bind to scaffolding proteins but with different affinities for the dystrophinassociated protein complex as well as SAP97, CASK, and Veli. 90 In 2001 Dart and Leyland showed that Kir2.1 associates with A kinase-anchoring protein (AKAP5), which is a multivalent-anchoring protein that binds PKA, PKC, and calcineurin. 91 AKAP5 is targeted to the intracellular N and C terminal domains of Kir2.1 to anchor kinases close to key channel phosphorylation sites and is required for appropriate modulation of channel function. 91 More recently, it was suggested that both Kir2.1 and AKAP are part of a macromolecular signaling complex that includes the β1-adrenergic receptor and SAP97. 92 Kir2.1 may also associate with caveolin3 (Cav3) in human cardiac cells. Cav3 mutations have been shown to reduce cell surface expression of Kir2.1 with consequent reduction of I K1 density. Such an effect may add to the previously described late I Na increase 35 and contribute to delayed repolarization and arrhythmia generation in Cav3-mediated LQT9. 93 Filamin-A increases the number of functional Kir2.1 channels on membrane in arterial smooth muscle cells. 94 It appears to act as a cytoskeletal anchoring protein for the Kir2.1 channel, stabilizing its surface expression. However, while filamin has been shown to localize at the Z lines in cardiomyocytes, 95 it is unknown whether pools of Kir2.x channels co-localize with filamin-A. Finally, it has been demonstrated that Kir2.1 interacts with the AP1 adaptin complex through an unusual Golgi exit signal dictated by a tertiary structure, localized within the confluence of the Kir2.1 cytoplasmic NH3 and COOH terminal domains. 96 The signal creates allows properly folded Kir2.1 channels to insert into clathrincoated vesicles at the trans-Golgi for export to the cell surface, which is a critical regulatory step for controlling trafficking and cell surface expression of the Kir2.x channels. 96 c. Kir2.1 and the Na V 1.5/Kir2.1 channelosome
There is a strong relationship between the inward I Na and the inward rectifier potassium current (I K1 ), the two most important ionic currents controlling ventricular excitability: by controlling the RMP, I K1 modifies Na + channel availability and therefore, cell excitability. 80 In addition, I K1 -I Na interactions are important in stabilizing and controlling the frequency of the electrical rotors that are responsible for the most dangerous cardiac arrhythmias, including ventricular tachycardia (VT) and VF. 88 Recent data demonstrated that the I Na -I K1 interplay involves a reciprocal modulation of expression of their respective channel proteins (Kir2.1 and Na V 1.5) forming a channelosome within a macromolecular complex (Fig. 6) . 9 Further, evidence suggests that conditions that result in Na V 1.5 protein reduction, such as it occurs in the dystrophin-deficient mdx 5cv mice, are accompanied by a concomitant reduction in Kir2.1 protein levels. 32 Importantly, the finding that co-expression of Na V 1.5 may reduce internalization of Kir2.1 was a central mechanistic observation, with important implications in the control of cardiac excitability and SCD. 9 Recently, Gillet et al investigated in vivo the interactions of SAP97 with Kir2.1 and Na V 1.5 by generating a genetically modified mouse model in which SAP97 expression was constitutively suppressed in cardiomyocytes. 26 As expected, I K1 was reduced in the SAP97 knockout mice (Fig. 7) . 9, 97 Unexpectedly, I Na , and Na V 1.5 localization at the intercalated disc, were unaffected by the loss of SAP97 expression. Ostensibly, the data presented by the papers of Gillet et al 26 and of Shy et al 25 regarding Na V 1.5 seem to contradict previous work. 8, 9, 97 Yet there are substantial differences between the two mouse models and the previous studies that need to be considered. Most important in both mouse models, 25, 26 genetic modification is present early in development, whereas in the other studies, 9 SAP97 expression was silenced in adult myocytes that were kept in culture. Therefore it is conceivable that the consequences on I Na could be different in an inducible SAP97 knockout mouse model. On the other hand, Na V 1.5 is known to interact with other regulatory proteins at the IDs, such as connexin43, 98-100 PKP2, 45 and ankyrin-G. 101 Furthermore, recent studies suggest that there are micro-domains of Na v 1.5 at the IDs. In particular a population of Nav1.5 is located at the periphery of gap junctions in a so-called perinexus region that has been proposed to be involved in ephaptic conduction. 102 It might be possible that constitutive deletion of SAP97 led to compensatory modifications in the expression and/or organization of one more partner proteins that contributed to maintain Na V 1.5 expression.
d. The KATP Channel Macromolecular Complex
ATP-sensitive K + (K ATP ) channels function as metabolic sensors in many cell types. 103 They are an octameric assemblies of a sulfonylurea receptor (SUR) and an ion conducting subunit (Kir6.x). 104 This enables them to directly couple their energy metabolism to cellular excitability and function as a crucial regulatory mechanism in the cell response to metabolic demand. 103 Genetic manipulation of cardiac K ATP subunits has revealed a role of these channels in arrhythmia generation. 105 Human K ATP mutations underlie different K ATP channelopathies and can substantially increase the risk for heart disease. 106 The pore forming subunit of the K ATP channel is one of two members of the inwardly rectifying family of K + channels, Kir6.1 and Kir6.2 coded by KCNJ11 and KCNJ8, respectively. The two SUR subunits (SUR1 and SUR2) are respectively coded by ABCC8 and ABCC9. 106 Although several SUR splice variants have been described, the most commonly studied are SUR1, SUR2A, and SUR2B. 107, 108 Like other Kir channels Kir6.x subunits have a cytoplasmic N and C terminus with two transmembrane domains and a pore forming H5 loop. 79, 106 SUR has multiple transmembrane domains with two large intracytoplasmic loops, the first and second nucleotide binding domains (NBD1 and NBD2), which contain consensus sequences for the hydrolysis of nucleotides (Walker A and B motifs). 109 Co-expression of the two types of subunit is necessary to achieve functional expression of K ATP channels and the assembly of a specific Kir6.x with a specific SUR generates currents with a particular single-channel conductance, nucleotide regulation and pharmacology. 103 However, accumulating evidence suggest that the K ATP channel protein complex is part of a multisubunit macromolecular complex that may also include additional metabolically active protein subunits, including adenylate kinase, creatine kinase, and lactate dehydrogenase. 110 In addition, it has been demonstrated that 14-3-3 proteins promote the cell-surface expression of heterologously expressed and native K ATP channels by functionally antagonizing the arginine-based endoplasmic reticulum (ER)-localization signal that many ion channels and proteins require to reach the cell surface, and that is present in SUR1. 111 Recently it was shown that KATP channels are stalled in the Golgi complex of ventricular, but not atrial, cardiomyocytes. 106 It was also demonstrated that PKA-dependent phosphorylation of the C-terminus of Kir6.2 by sustained β-adrenergic stimulation leads SUR1-containing channels to reach the plasma membrane of ventricular cells by silencing the arginine-based retrieval signal. Therefore, it was suggested that sympathetic nervous stimulation might enable adaptation to metabolic challenges by releasing K ATP channels from storage in the Golgi. 106 In a recent proteomics study, glycolytic enzymes previously described for the K ATP channel complex were shown to co-immunoprecipitate with K ATP channel subunit from heart, endothelium, and pancreas, 108 suggesting that glycolytic ATP production contributes to fine tuning of K ATP channel opening in these tissues.
Physical interaction between cardiac K ATP channels and the Na + /K + ATPase has also been suggested, which might provide mechanistic insight into their functional interaction with regards to possibly sharing or competing for the same local pool of submembrane ATP/ ADP. 112 Finally, Kir6.2 and SUR2A are expressed at a higher density at the IDs in mouse and rat hearts, where they co-localized with PKP2 and plakoglobin. The disruption of the desmosomal complex in PKP2 deficient mice results in downregulation of K ATP channels, suggesting a possible role of these channels in cell-to-cell communication. 113 
Diversity of Kv channels
Voltage-gated potassium (Kv) channels are members of the Shal subfamily of voltage-gated K + channel pore-forming α subunits. 114 Kv channels are formed by assemblies of four α-subunits plus accessory subunits. 115 They function to control resting membrane potentials, shape AP characteristics and influence the responses to neurotransmitters and neurohormones. There are extensive differences in their kinetics of activation and inactivation among the various Kv channels, and specific channels underlie specific currents in the heart. For example, Kv4.x channels, including K V 1.4, K V 4.2 and K V 4.3, coded by KCNA4, KCND2 and KCND3, respectively, activate and inactivate rapidly and underlie the I to (transient outward current). 114 K V 1.5, which is coded by KCNA5 and forms the atriaspecific ultrarapid delayed rectifier K + current (I Kur ), inactivates much more slowly. 116 Kv7.1 is coded by KCNH2 , 117 the human ether-a-go-go-related gene (hERG). In contrast to Kv4.1-3, hERG activates and inactivates rapidly, then conducts most of its current during its recovery from inactivation. Kv2.1, coded by KCNB1, is a slow delayed-rectifier K + channel that underlies I k,slow2 in rat cardiomyocytes. 118, 119 Targeted elimination of K V 2 channels in mouse ventricular myocytes leads to prolongation of the action potential duration and the QT interval. 120 K V 2.1 may have distinct physiological roles in atrial and ventricular myocytes. 119 Finally, I Ks , the α subunit (KCNQ1) of the slowly activation delayed-rectifier K + current activates and deactivates slowly. 121 
a. Functional interactions of Kv channels in their microenvironment
In the heart, Kv4.2, Kv4.3 and/or Kv1.4 may assemble to generate transient outward currents. Kv4.3/Kv4.2 subunits form the rapidly recovering I to,f channels, whereas Kv1.4 forms the slowly recovering Ito channel, both of which underlie the early phase of AP repolarization and contribute to the AP plateau. 122 Both channel types are differentially expressed in the ventricles, contributing to regional heterogeneities in AP shape and duration. 123 Substantial evidence indicates that these channels function as integral components of macromolecular protein complexes, 114 and that expressed K V channels can be regulated by post-translational modifications, including phosphorylation. 114 Also co-expression with accessory or regulatory proteins in heterologous expression systems modifies cell surface expression, subcellular distribution, channel stability, and biophysical properties of K V 4 channels. 124 Hence, the specificity of channel-mediated signal transduction is most likely the result of association of these integral membrane proteins with discrete sets of partner proteins or from their assembly into stable macromolecular complexes. 125 However, the information available about the functioning of accessory subunits and other regulatory proteins in the generation and regulation of native cardiac Kv channels is limited. 126 
b. β-Subunits and Voltage-Dependent K + Channels
The β-subunits of Kv channels (Kvβ) are cytoplasmic proteins that have a mass of ~40 kDa. Nine Kvβ-subunits are encoded by 4 genes. They have been shown to associate with Kv α-subunits. The Kvβ1, Kvβ2, and Kvβ3 proteins, which are coded by different genes, are the only Kvβ proteins expressed in the mammalian heart. 114 Additional variability is produced by alternative splicing on the N-terminal region. Kvβ subunits are localized in the cytosol with a conserved carboxyl-terminal and a variable amino-terminal; they form a tetrameric structure and are associated in a 1:1 ratio with the α-subunit. Kvβ1 and Kvβ3 associate with α-subunits early during their biosynthesis in the endoplasmic reticulum and exert a chaperone-like effect enabling their stable expression at the plasma membrane. 127 Notably, this chaperone-like property of Kvβ-subunit does not apply to all Kv channels. 115 The most important effect of Kvβ1 on the voltage-dependent outward current is to accelerate its rate of inactivation, an effect that is mediated trough a "ball-and-chain" like process whereby the Kvβ1 N-terminal domain blocks the inner cavity of the Kv α-subunit pore. 128 In addition, by binding to the C-terminus of the Kv channel Kvβ can accelerate the C-type inactivation. 129 In heterologous expression systems co-expression of Kvβ1.3 with Kv1.5 is necessary for the cAMP-dependent PKA-mediated increase in K + current. 130 Moreover, consistent with the presence of multiple phosphorylation sites on the α-and β-subunits, PKC reduces the K + current of Kv1.5 channels only when co-expressed with Kvβ1.2, 131 which may provide an explanation for the effects of the β-adrenergic or PKC stimulation on I Kur in human atrial myocytes. 132 The duration and the frequency of membrane depolarization can significantly modify the rate of inactivation of I kur in human atrial myocytes. This effect is modulated by the activation of CaMKII and may also involve the interaction between Kvβ and the Kvα1.5 subunits. 133 The contribution of I kur to the abbreviation of the AP duration during atrial fibrillation 134 and the fact that the Kv1.5 channel is more abundantly expressed in atrial than ventricular myocardium are additional examples of the important role played by Kvβ subunits in cardiac pathophysiology. 116 Finally, Kvβ subunits have been shown to confer sensitivity to redox modulation and hypoxia to Kv4.2 channels. 135 
c. Other Ancillary Subunits of K V channels
The best-known partner of Kv4 channels is the cytoplasmic Kv channel-interacting protein KChIP2, which has been shown directly to be an essential component of I to,f channels in myocardium. The KChIPs were first identified in brain using the Kv4 N-terminus as bait in a yeast two-hybrid screen. 136 They were shown to have four EF-hand-like domains and bind calcium ions. The expression of KChIP and Kv4 together reconstitutes several features of native A-type currents by modulating the density, inactivation kinetics and rate of recovery from inactivation of Kv4 channels in heterologous cells. 136 All three KChIPs were shown to co-localize and co-immunoprecipitate with brain Kv4 α-subunits, and therefore to be integral components of native Kv4 channel complexes. 136 KChIP2 assembles with the N terminus of the pore-forming Kv4 α subunit and acts as a chaperone to regulate both surface expression and electrophysiological properties of the channel. 137 In heart, KChIP2 coimmunoprecipitates with α subunits of Kv4.2 and Kv4.3 from adult mouse ventricles, and the targeted deletion of the mouse KChIP2 locus (Kcnip2) abolishes ventricular I to,f . 138 In addition, KChIP2 protein expression is highly reduced in the ventricles of homozygous Kv4.2 knockout mice, suggesting that Kv4 and KChIP2 proteins reciprocally regulate each other's expression. 138, 139 In mouse ventricles the KChIP2 mRNA level is somewhat larger in the epicardium than the endocardium. 140 In contrast, large transmural gradients in KChIP2 expression together with large It o,f density gradients have been demonstrated across the human and the dog ventricular walls. 139 Dipeptidyl peptidase-like protein 6 (DPP6) is protein that regulates the activation and inactivation properties of cardiac Kv4 channels. 114,141 DPP6 increases heterologouslyexpressed Kv4 α subunits at the cell surface, 142 shifts the voltage dependences of activation and inactivation currents to more negative potentials, and accelerates the rates of current activation, inactivation and recovery. 141143 Notably, when DPP6 is co-expressed with Kv4.3 and KChIP2, it yields Kv currents that closely resemble native cardiac I to,f . 141 Transient outward K + currents can be modulated by protein kinases. 144 The non-receptor protein tyrosine kinase c-Src is a member of a family of nine closely related membranebound kinases defined by a common structure with a catalytic kinase domain and aminoterminal regulatory regions termed Src homology 2 (SH2) and 3 (SH3) domains. 145 These modular domains mediate intramolecular and intermolecular interactions that are important in signal transduction. The Kv4.3 sequence contains SH2 and SH3 domain binding motifs, making Kv4.3 a strong candidate for direct interaction with and/or phosphorylation by c-Src. Gomes et al have shown through GST pull-down assays and co-immunoprecipitation, that Kv4.3 protein associates with c-Src and that the SH2 and SH3 domains of the kinase mediate this interaction, which may result in enhanced efficiency of Kv4.3 phosphorylation by c-Src leading to rapid modulation of Kv4.3 channel activity. 146 SAP97 and Kv1.5 subunits can interact, directly or indirectly, both in the heart and in heterologous systems. 137, 147 Adenoviral overexpression of SAP97 in neonatal rat atrial myocytes leads to clustering of endogenous Kv1.5 subunits at myocyte-myocyte contacts and an increase in both I Kur and the number of 4-aminopyridine-sensitive potassium channels in cell-attached membrane patches. 148 On the other hand, pull-down and coimmunoprecipitation assays in cardiac myocytes showed that the Kv4 channel C terminus, SAP97, and CaMKII interact together, and that the interaction is suppressed by SAP97 silencing and enhanced by SAP97 overexpression. 137 In HEK293 cells, SAP97 silencing reproduced the effects of CaMKII inhibition on current kinetics and suppressed Kv4/ CaMKII interactions. Altogether, the above data suggest that SAP97 is a major partner for surface expression and CaMKII-dependent regulation of cardiac Kv4 channels.
As reviewed comprehensively elsewhere, 114 KCNE genes encode a family of single transmembrane domain proteins called minK-related peptides (MiRPs) that function as accessory beta subunits of Kv channels. When co-expressed in heterologous systems, MiRPs confer changes in Kv channel conductance, gating kinetics and pharmacology. 114 Coexpression of Kv4 and Kv4-KChIP2 channels with MiRP1 affects the kinetics and the voltage dependent properties and recapitulates the "overshoot" in peak current amplitude during current recovery, 149 that is evident in human epicardial I to,f . 114, 150 Inherited mutations in KCNE genes are associated with diseases of cardiac and skeletal muscle, and the inner ear. 151, 152 For example, aspartate to asparagine substitution to yield p.D76N-MinK is linked to cardiac arrhythmia and deafness. Mutation of arginine to histidine (p.R83H) in MiRP2 is associated with periodic paralysis. 151 Finally, targeted deletion of Kcne2, which encodes MiRP1, reduced (~25%) ventricular Ito,f densities by 25% with negligible changes in total or surface Kv4.2 expression. 153 TheKCNE1 gene encodes a 129 amino acid protein in mouse and human that modifies the currents generated by hERG or KvLQT1. The delayed rectifier K + currents resulting from expression of KvLQT1 alone are small and activate very rapidly, but I Ks is reconstituted when minK is coexpressed with KvLQT1. 154 Evidence suggests that KCNE1 may have preferential expression in the conduction system. 155 Mutations in KCNE1 have been reported to cause LQTS. 156 MiRP2 is a member of the MinK-related peptide family that is coded by KCNE3. It coimmunoprecipitates with Kv4.3 from human atria. 157 Interestingly, a missense mutation (p.R99H) in KCNE3 was identified in a family with BrS. 157 Co-transfection of MiRP2 (with and without KChIP) decreases Kv4.3 current densities in heterologous expression systems. 157, 158 In addition, co-expression of the p.R99H MiRP2 mutant reversed the inhibitory effects of wild type MiRP2 on Kv4.3 currents. 157 Altogether, the above data suggest that MiRP2 is required for normal functioning of human Ito,f channels and that gain of function mutations in MiRP2 predispose to BrS through augmentation of Ito,f. 114, 157
6.KCNQ1 (KvLQT1)
The KCNQ1 gene, encodes the Kv7.1 channel protein, which can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. 159 In the human heart the KCNQ1 encodes the pore-forming α subunit, and KCNE1 (also known as minK) encodes the regulatory β subunit of the KCNQ1-KCNE1 complex responsible for I Ks , the slowly activating delayed rectifier K + repolarizing current. 160 Mutations in KCNQ1 are associated with hereditary LQTS1 (also known as Romano-Ward syndrome), Jervell and LangeNielsen syndrome, and familial atrial fibrillation. 161 In 2002, Marx et al showed that modulation of I KS β-adrenergic receptor stimulation requires targeting of cyclic adenosine 3′,5′-monophosphate (cAMP)-dependent PKA and protein phosphatase 1 (PP1) to hKCNQ1 through the A kinase-anchoring protein (AKAP)-9, also known as yotiao. 121 These authors elegantly demonstrated that yotiao binds to the human KCNQ1 by a leucine zipper motif, which is disrupted by an LQTS mutation (hKCNQ1-G589D). Identification of the hKCNQ1 macromolecular complex provides a mechanism for sympathetic nervous system modulation of cardiac APD through I KS . 121 These data provided compelling evidence that the cardiac I Ks potassium channel is a macromolecular complex consisting of α-(KCNQ1) and β-subunits (KCNE1) and yotiao (AKAP-9), which recruits PKA and protein phosphatase 1 to the channel. 121 
Kv11.1-HERG
The human erg protein (hERG or Kv11.1) is the pore-forming subunit of the rapid component of the cardiac delayed rectifier potassium current (I K ) responsible for AP repolarization. 162 It is encoded by the hERG gene, 163 which comprises three members, erg1, erg2, and erg3, displaying varying expression patterns in different tissues; 164 herg1 is the best characterized. 163 Structurally, hERG has six transmembrane domains (S1-S6), S4-being the voltage sensor, with cytosolic N and C termini. The N terminus, which contains a PAS domain, strongly affects the biophysical properties of the channel. Functional hERG channels are tetramers with a pore region responsible for K + current flow through the plasma membrane. 162 As reviewed elsewhere, alternative transcription of hERG1 results in two identical proteins, hERG1a and hERG1b, that diverge only in their N-termini. 165 hERG1b can form channels alone or co-assemble with hERG1a. A third variant of hERG1, also identical to hERG1a but with a modified C-terminus is termed hERGuso. 166 Expression of hERGuso reduces the number of channels at the sarcolemma and the current density. In contrast, co-assembly with hERG1b alters channel kinetics increasing channel availability current magnitude. 167 Mutations in hERG lead to long-QT syndrome type 2 (LQT2), a major cause of arrhythmias, 168 as well as to short QT syndrome type 2, which results in atrial and ventricular arrhythmias. 169 Even though heterologously expressed hERG channels are largely indistinguishable from native cardiac I Kr , a role for KCNE1 in this current was suggested by the diminished I Kr in an atrial tumor line subjected to minK antisense suppression. 170 Subsequently, McDonald et al showed that HERG and minK formed a stable complex, and that the heteromultimerization regulated I Kr activity. This provided additional support for the idea that minK, through the formation of heteromeric channel complexes, is central to the control of the heart rate and rhythm. 171 hERG has been shown to also co-immunoprecipitate with PKA 172 , and similar to other cardiac K V channel subunits hERG interact with SNAREs, which are proteins that are critical for synaptic vesicular secretion and possibly membrane protein trafficking. 173 Recently, Ma et al 168 identified 23 potential interacting proteins that may regulate cardiac I Kr through cytoskeletal interactions, G-protein modulation, phosphorylation and downstream second messenger and transcription cascades. Fifteen such proteins were identified as hERG amino terminal (hERG-NT)-interacting proteins, including the caveolin-1, the zinc finger protein FHL2 and protein tyrosine phosphatase non-receptor type 12 (PTPN12). The other 8 proteins were identified as hERG carboxylic terminal (hERG-CT)-interacting proteins, including the NF-κB-interacting protein myotrophin. 168 Several unexpected binding partners were identified which greatly enhanced the dynamic modulation of IKr as part of a macromolecular complex. 168 
KCNQ1-HERG interactions
After the pioneering studies of Sanguinetti et al, 154 it became clear that I K , the delayed rectifying K current responsible for cardiac repolarization, is mediated by two distinct currents, I Kr and I Ks , which work together to produce cardiac repolarization and control the APD. Recent results suggest that in addition to their voltage dependent interactions, these two channels also interact at the molecular level. 174 For example, studies in both transgenic LQT rabbit cardiomyocytes and stable, heterologous cell lines reported that hERG and KCNQ1 underwent reciprocal, functional downregulation in that co-expression of wild-type or dominant-negative pore mutants of KCNQ1 significantly reduced hERG currents, and vice versa. 175 More recently, the same lab conducted acceptor photobleach Förster resonance energy transfer (FRET) experiments and demonstrated that the intermolecular KCNQ1-hERG interactions are direct and mediated by their respective COOH termini. 174 In agreement with the above results, another group showed that KCNQ1 preferentially coimmunoprecipitated with mature hERG channels that were localized in the plasma membrane of HEK293 cells. 176 On the other hand, the latter group demonstrated that while hERG channels undergo rapid endocytic degradation upon exposure to hypokalemia, KCNQ1 channels are relatively insensitive to extracellular K + reduction. 176 Thus when hERG and KCNQ1 were expressed separately, exposure to 0 mM K + for 6 h completely eliminated the mature hERG channel expression but had no effect on KCNQ1. However, contrary to the transgenic rabbit data, 174 the latter investigators showed that when hERG and KCNQ1 were co-expressed, KCNQ1 significantly delayed the hypokalemia-induced hERG loss. 176 Also, hERG degradation led to a significant reduction in KCNQ1 in hypokalemia. 176 Therefore while biophysical and pharmacological analyses conducted by both groups indicate that hERG and KCNQ1 closely interact with each other, their respective results seem to go in the opposite direction: the former group concluded that coexpression of KCNQ1 significantly reduced hERG currents and vice versa, 174 whereas the latter group concluded that co-expression of KCNQ1 protected hERG against hypokalemia, and hERG reduction reduced KCNQ1. 176 Clearly additional studies will be necessary to resolve this controversy.
Perspectives and Conclusions
We have briefly reviewed research conducted over the last 20 years showing that cardiac ion channels may function as part of large macromolecular complexes. Such complexes play crucial roles the transcription, translation, oligomerization, trafficking, membrane retention, glycosylation, posttranslational modification, turnover, function and degradation of all cardiac ion channels known to date. In fact, macromolecular complexes are vital to a wide collection of cellular tasks. Some of these require physical contact among partner proteins, others do not. Understanding the structure and signaling dynamics of multiprotein assemblies is vital to understanding their function, and is likely to shed light on how the heart functions in health and disease. However, we are still lacking a detailed knowledge of such processes, and of the role played by the myriad of ion channel molecular assemblies in the compartmentalization of ion channel function and the mechanisms underlying ion channel dysregulation, life-threatening cardiac arrhythmias and SCD. This is a significant problem because both arrhythmias and SCD are among the most important causes of cardiovascular morbidity and mortality in the developed world. Clearly, many more studies are needed to establish new paradigms of cardiac electrophysiology integrating the large diversity of molecular interactions involved in the formation, targeting and regulation of cardiac ion channels and their function, as well as the tissue specific expression of the components of ion channel complexes not only in the working cardiac muscle of the atria and ventricles, but also the specialized pacemaking and conduction systems. Progress likely will come from the use of systems biology approaches, from the nanoscale all the way to the cellular and organ levels. Progress should also derive from the development and application of modern technologies enabling adequate spatio-temporal resolution to visualize and quantify the processes involved in the assembly and dynamic interactions of ion channel macromolecular complexes in living native myocytes from animal models, as well as in human stem-cell derived cardiomyocytes.
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Short-QT syndrome Topography of Na V 1.5 channel and its interacting proteins. The proteins for which a binding site has been mapped are represented: 14-3-3 protein _-isoform, calmodulin-dependent protein kinase II delta-c, MOG1, ankyrin-g, fibroblast growth factor like 13, calmodulin, Nedd4-2 like ubiquitin ligases, syntrophin proteins adapting either dystrophin or utrophin, protein tyrosine phosphatase-H1, synapse associated protein-97. The proteins with question marks were found to interact with Na V 1.5 but the sites of interaction are not yet known (CAR is coxsackie and adenovirus receptor, Desmogl-2 is desmoglein-2). Only one of the four beta subunits is represented (in red). (A) Proximity ligation assay staining using antibodies for Na V 1.5 and pan-syntrophin demonstrating the specific location of the interaction between these two proteins at the lateral membranes of mouse cardiac cells (red dots). In green, immunofluorescence staining demonstrating the present of connexin-43 at the IDs (modified with permission from Shy et al. 2014 ). (B) Depending on the partner proteins they interact with, Na V 1.5 is found either at the ID region, or at the lateral membrane (composed of crest regions and T-tubules) of cardiomyocytes. Along the crests, functional sodium channels do not distribute homogenously, but segregate in densely-populated clusters, coexisting with areas devoid of functional channels. (Upper panels) Isolated mouse ventricular myocyte with double immunofluorescence staining (imaged with confocal microscopy). Na V 1.5 (green) is expressed at the IDs, lateral membrane. The punctate staining most-likely represents the expression at the t-tubules. Syntrophin is only expressed at the lateral membrane where it co-localize with Na V 1. 
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